Develops prescription medicines and dietary supplements, including TNG, Carotilen and Physiolong.
10-K for FY2025, filed Mar 25, 2026On April 7, 2022, the Company signed with “VITAL FE” Joint Stock Company (“VITAL”) an Exclusive Rights Agreement for a term of 15 years for…View ↗
On April 7, 2022, signed with “MICAR 11” LTD. (“MICAR”) an Exclusive Rights Agreement for a term of 15 years for the production and…View ↗
On August 1, 2022, the Company signed a Joint Business Agreement with Immunotech Laboratories BG, Ltd. through which the two companies are…View ↗
No revenue reported yet.
10-K for FY2024, filed Mar 31, 2025
10-Q for Q2 FY2026, filed Aug 10, 2026
−$19.7KView ↗
Loading...